Hybrid Work Strategies: 3 Tips to Transform Engagement
In this post-COVID era, our clients have experienced a culture shift — driven…
Medical Affairs: An Orchestra, Not a Horse Race
Every horse race has a starting bell, a push to move as fast as possible, and a…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more…
What’s the Latest?
There are many ways we introduce ourselves to make an impact and grab the…
Spotlight on Transitions
This topic of “transition” came home to me (literally and figuratively) over the Thanksgiving holiday. With our adult kids returning, my husband and…
Networking in Biopharma: Four Ways to Build Better Relationships
Networking! You know, that activity that one either embraces or goes running away from as quickly as possible. For many, the word evokes a grueling,…
Biopharma Brand Team and Launch Team Structure: A Practical Guide
For those of you following closely (thank you!), you may recall that in an earlier e-conversation — 21st Century Commercialization — More than a…
Biopharma Governance and Decision-Making: How to Fix What’s Broken
At your next company lunch and learn, try this experiment: Ask ten people from different functions to take a blank piece of flip chart paper…
Reading Recommendations from the High Cs
Summer is a wonderful time for catching up on our reading – whether business, pleasure, or something in between. This month, we sought out…
Are Your Assumptions Serving You Well?
Ah, June, the season of life transitions — weddings, graduations, school progression and, with the year nearly half over, a reminder to reflect on…
The Future of Biopharma Commercialization Strategy Is Now
Back in the early 2000s, I was head of commercial strategy at Millennium Pharmaceuticals in Cambridge, Massachusetts. I remember saying to then CEO,…
Biopharma Launch Planning for Emerging Companies: Four Key Challenges
Living in a parallel universe, launching a company and drug simultaneously.